Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
All‐oral 12‐week treatment with daclatasvir plus sofosbuv... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study
0
Authors
David Nelson
26 more
David Nelson
•
James Cooper
24 more
•
Eric Hughes
Published
January 23, 2015
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Hepatology
Topics
Medicine
Epidemiology
Internal Medicine
Gastroenterology
Hepatology
Show all topics
DOI
10.1002/hep.27726
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Hepatology
Topics
Medicine
Epidemiology
Internal Medicine
Gastroenterology
Hepatology
Show all topics
DOI
10.1002/hep.27726
License
CC-BY-NC-ND
Other Formats
PDF
